These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
574 related items for PubMed ID: 2854365
1. Comparison of the susceptibility of falciparum malaria to mefloquine-sulphadoxine-pyrimethamine and chloroquine in Nigeria. Fadeke Aderounmu A, Salako LA, Laoye AJ, Modupe Makinde J, Aina Adio R. Afr J Med Med Sci; 1988 Dec; 17(4):195-200. PubMed ID: 2854365 [Abstract] [Full Text] [Related]
2. Sensitivity of Plasmodium falciparum to mefloquine-sulphadoxine-pyrimethamine (Fansimef) in vivo and to mefloquine alone in vitro in Nigeria. Salako LA, Aderounmu AF, Laoye JO, Makinde JM, Adio RA. Ann Trop Med Parasitol; 1988 Aug; 82(4):325-30. PubMed ID: 3075441 [Abstract] [Full Text] [Related]
3. [Uncomplicated malaria attack in an area with high resistance to chloroquine. 3. The use of second-choice oral drug treatment]. Hengy C, Eberlé F, Gazin P, Kouka-Bemba D, Gelas H, Jambou R. Bull Soc Pathol Exot; 1990 Aug; 83(1):61-5. PubMed ID: 2190706 [Abstract] [Full Text] [Related]
4. [A case of malaria tropicameningoencephalitis (neuromalaria) with chloroquine and pyrimethamine/sulfadoxine resistance]. Niklewski G, Landscheidt H, Glasner H. Nervenarzt; 1985 Feb; 56(2):101-5. PubMed ID: 3885058 [No Abstract] [Full Text] [Related]
5. A double-blind trial of a fixed combination of mefloquine plus sulfadoxine-pyrimethamine compared with sulfadoxine-pyrimethamine alone in symptomatic falciparum malaria. Ekue JM, Phiri DE, Sheth UK, Mukunyandela M. Bull World Health Organ; 1987 Feb; 65(3):369-73. PubMed ID: 3311440 [Abstract] [Full Text] [Related]
6. Tolerability of long-term malaria prophylaxis with the combination mefloquine + sulfadoxine + pyrimethamine (Fansimef): results of a double blind field trial versus chloroquine in Nigeria. Kollaritsch H, Stemberger H, Mailer H, Kremsner P, Kollaritsch R, Leimer R, Wiedermann G. Trans R Soc Trop Med Hyg; 1988 Feb; 82(4):524-9. PubMed ID: 2908258 [Abstract] [Full Text] [Related]
7. A phase II/III double-blind, dose-finding clinical trial of a combination of mefloquine, sulfadoxine, and pyrimethamine (Fansimef) in falciparum malaria. de Souza JM, Sheth UK, Wernsdorfer WH, Trigg PI, Doberstyn EB. Bull World Health Organ; 1987 Feb; 65(3):357-61. PubMed ID: 3311438 [Abstract] [Full Text] [Related]
15. Comparative efficacy and safety of chloroquine and alternative antimalarial drugs: a meta-analysis from six African countries. Mengesha T, Makonnen E. East Afr Med J; 1999 Jun; 76(6):314-9. PubMed ID: 10750517 [Abstract] [Full Text] [Related]
16. Treatment of malaria in north-eastern and south-eastern Nigeria: a population study of mefloquine, sulphadoxine, pyrimethamine combination (MSP) vs chloroquine (CQ). Ekanem OJ, Ezedinachi EN, Molta NB, Watila IM, Chukwuani CM, Meremikwu MM, Akpede G, Ojar EA. West Afr J Med; 2000 Jun; 19(4):293-7. PubMed ID: 11391844 [Abstract] [Full Text] [Related]
17. Comparison of chloroquine, sulfadoxine/pyrimethamine, mefloquine and mefloquine-artesunate for the treatment of falciparum malaria in Kachin State, North Myanmar. Smithuis F, Shahmanesh M, Kyaw MK, Savran O, Lwin S, White NJ. Trop Med Int Health; 2004 Nov; 9(11):1184-90. PubMed ID: 15548314 [Abstract] [Full Text] [Related]
19. Randomized comparison of chloroquine plus sulfadoxine-pyrimethamine versus artesunate plus mefloquine versus artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in the Lao People's Democratic Republic. Mayxay M, Khanthavong M, Lindegårdh N, Keola S, Barends M, Pongvongsa T, Yapom R, Annerberg A, Phompida S, Phetsouvanh R, White NJ, Newton PN. Clin Infect Dis; 2004 Oct 15; 39(8):1139-47. PubMed ID: 15486837 [Abstract] [Full Text] [Related]